Trump issues 100% tariffs on patented drugs, boosting US supply chain
President Trump signed an executive order imposing 100% tariffs on patented drugs to boost US production and strengthen the pharmaceutical supply chain. The plan is framed as a national security move, but it may trigger EU retaliation, with the risk extending through September 30. The EU’s potential response rate remains unclear.
The order allows companies to avoid the 100% tariffs on patented drugs by using “Most-Favored-Nation” pricing agreements. Japan and the EU reportedly receive a preferential 15% rate. Analysts and traders are watching for signals of a trade-war escalation, including statements from the EU Commission, the USTR, and major US importers, as any retaliation or negotiations could affect broader macro conditions.
Market cross-links mentioned include “US Recession 2026” and Fed rate decision expectations, which can influence risk appetite across assets, including crypto. Trading volume is noted as low, but the executive order has already stirred interest in related prediction and macro-focused markets. Investors should treat it as headline-driven volatility risk around late September and monitor diplomatic developments closely.
Neutral
这条新闻的核心是“专利药品100%关税”可能引发欧盟报复，并在9月30日前后形成宏观不确定性。对加密市场而言，关税与贸易战通常会通过风险偏好、流动性预期和美元/利率路径影响情绪：若冲突升级，风险资产（含加密）往往更容易出现波动；若出现谈判降温，波动也可能回落。
文中同时提到通过最惠国定价可规避“专利药品100%关税”，以及日本/欧盟15%优惠税率，这些细节意味着并非所有相关成本都会线性上升，边际影响可能被部分缓冲。但由于欧盟是否反制仍未知，短期更像是“事件驱动的情绪波动”，而不是单边、可立即量化的盈利/损失冲击。
类似的贸易摩擦升级往往在早期造成不确定性溢价上升；随后若出现明确谈判或豁免政策，市场会重新定价风险。考虑到文章强调的是政策风险窗口与后续等待确认（欧盟回应、USTR与进口商表态），因此对加密的方向性影响更偏中性：更可能带来波动而非趋势性单边行情。交易上可关注9月30日前后的宏观情绪变化与相关风险资产联动，而非立即追涨或追跌。